Gastric Bypass Surgery Reverses Diabetic Phenotypes in Bdnf-Deficient Mice

American Journal of Pathology

Volumn 186, Issue 8, 2016, Pages 2117-2128

  Jiang, Shujun ^a   Wang, Qinghua ^a,b   Huang, Zan ^c   Song, Anying ^a   Peng, Yu ^c   Hou, Siyuan ^a   Guo, Shiying ^a   Zhu, Weiyun ^c   Yan, Sheng ^d   Lin, Zhaoyu ^a   Gao, Xiang ^a  

^a NANJING UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; VERY LOW DENSITY LIPOPROTEIN;

ACTINOBACTERIA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FIRMICUTES; GASTRIC BYPASS SURGERY; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTESTINE FLORA; LIPID STORAGE; MACROPHAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOBACTERIA; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; DEFICIENCY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GASTRIC BYPASS; GASTROINTESTINAL MICROBIOME; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84990029539     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.04.009     Document Type: Article

References (43)

1. 1 Despres, J.P., Lemieux, I., Abdominal obesity and metabolic syndrome. Nature 444 (2006), 881–887.
2. 2 Van Gaal, L.F., Mertens, I.L., De Block, C.E., Mechanisms linking obesity with cardiovascular disease. Nature 444 (2006), 875–880.
3. 3 Zhang, H., DiBaise, J.K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M.D., Wing, R., Rittmann, B.E., Krajmalnik-Brown, R., Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106 (2009), 2365–2370.
4. 4 Karra, E., Yousseif, A., Batterham, R.L., Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 21 (2010), 337–344.
5. 5 Dirksen, C., Bojsen-Moller, K.N., Jorgensen, N.B., Jacobsen, S.H., Kristiansen, V.B., Naver, L.S., Hansen, D.L., Worm, D., Holst, J.J., Madsbad, S., Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass. Diabetologia 56 (2013), 2679–2687.
6. 6 Ochner, C.N., Gibson, C., Shanik, M., Goel, V., Geliebter, A., Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes 35 (2011), 153–166.
7. 7 Ashrafian, H., le Roux, C.W., Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation. Physiol Behav 97 (2009), 620–631.
8. 8 Suzuki, K., Simpson, K.A., Minnion, J.S., Shillito, J.C., Bloom, S.R., The role of gut hormones and the hypothalamus in appetite. Endocr J 57 (2010), 359–372.
9. 9 Olefsky, J.M., Glass, C.K., Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72 (2010), 219–246.
10. 10 Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu Rev Immunol 29 (2011), 415–445.
11. 11 Talukdar, S., Oh da, Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., Lu, M., Li, P., Yan, Q., Zhu, Y., Ofrecio, J., Lin, M., Brenner, M.B., Olefsky, J.M., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 18 (2012), 1407–1412.
12. 12 Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., Camporez, J.P., Shulman, G.I., Gordon, J.I., Hoffman, H.M., Flavell, R.A., Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482 (2012), 179–185.
13. 13 Ryan, K.K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Perez, H.E., Sandoval, D.A., Kohli, R., Backhed, F., Seeley, R.J., FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509 (2014), 183–188.
14. 14 Liou, A.P., Paziuk, M., Luevano, J.M. Jr., Machineni, S., Turnbaugh, P.J., Kaplan, L.M., Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med, 5, 2013, 178ra41.
15. 15 Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jorgensen, T., Brandslund, I., Nielsen, H.B., Juncker, A.S., Bertalan, M., Levenez, F., Pons, N., Rasmussen, S., Sunagawa, S., Tap, J., Tims, S., Zoetendal, E.G., Brunak, S., Clement, K., Dore, J., Kleerebezem, M., Kristiansen, K., Renault, P., Sicheritz-Ponten, T., de Vos, W.M., Zucker, J.D., Raes, J., Hansen, T. MetaHIT consortium, Bork, P., Wang, J., Ehrlich, S.D., Pedersen, O., Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
16. 16 Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L., Mariat, D., Corthier, D., Doré, J., Henegar, C., Rizkalla, S., Clément, K., Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59 (2010), 3049–3057.
17. 17 Li, J.V., Ashrafian, H., Bueter, M., Kinross, J., Sands, C., le Roux, C.W., Bloom, S.R., Darzi, A., Athanasiou, T., Marchesi, J.R., Nicholson, J.K., Holmes, E., Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60 (2011), 1214–1223.
18. 18 Nadal, I., Santacruz, A., Marcos, A., Warnberg, J., Garagorri, J.M., Moreno, L.A., Martin-Matillas, M., Campoy, C., Marti, A., Moleres, A., Delgado, M., Veiga, O.L., Garcia-Fuentes, M., Redondo, C.G., Sanz, Y., Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes (Lond) 33 (2009), 758–767.
19. 19 Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M., Magness, S., Jobin, C., Lund, P.K., High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One, 5, 2010, e12191.
20. 20 Lee, Y.S., Li, P., Huh, J.Y., Hwang, I.J., Lu, M., Kim, J.I., Ham, M., Talukdar, S., Chen, A., Lu, W.J., Bandyopadhyay, G.K., Schwendener, R., Olefsky, J., Kim, J.B., Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60 (2011), 2474–2483.
21. 21 Sha, H., Xu, J., Tang, J., Ding, J., Gong, J., Ge, X., Kong, D., Gao, X., Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice. Physiol Genomics 31 (2007), 252–263.
22. 22 Woods, M., Lan, Z., Li, J., Wheeler, M.B., Wang, H., Wang, R., Antidiabetic effects of duodenojejunal bypass in an experimental model of diabetes induced by a high-fat diet. Br J Surg 98 (2011), 686–696.
23. 23 Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M., Wynshaw-Boris, A., Poli, G., Olefsky, J., Karin, M., IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11 (2005), 191–198.
24. 24 Huber, J.A., Mark Welch, D.B., Morrison, H.G., Huse, S.M., Neal, P.R., Butterfield, D.A., Sogin, M.L., Microbial population structures in the deep marine biosphere. Science 318 (2007), 97–100.
25. 25 Junemann, S., Prior, K., Szczepanowski, R., Harks, I., Ehmke, B., Goesmann, A., Stoye, J., Harmsen, D., Bacterial community shift in treated periodontitis patients revealed by ion torrent 16S rRNA gene amplicon sequencing. PloS ONE, 7, 2012, e41606.
26. 26 Kashyap, S.R., Gatmaitan, P., Brethauer, S., Schauer, P., Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med 77 (2010), 468–476.
27. 27 Rubino, F., Schauer, P.R., Kaplan, L.M., Cummings, D.E., Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 61 (2010), 393–411.
28. 28 Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003), 1821–1830.
29. 29 Saltiel, A.R., Kahn, C.R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001), 799–806.
30. 30 Amar, S., Zhou, Q., Shaik-Dasthagirisaheb, Y., Leeman, S., Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci U S A 104 (2007), 20466–20471.
31. 31 Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., Arcaro, G., Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 30 (2007), 2119–2121.
32. 32 Verbeek, J., Lannoo, M., Pirinen, E., Ryu, D., Spincemaille, P., Vander Elst, I., Windmolders, P., Thevissen, K., Cammue, B.P., van Pelt, J., Fransis, S., Van Eyken, P., Ceuterick-De Groote, C., Van Veldhoven, P.P., Bedossa, P., Nevens, F., Auwerx, J., Cassiman, D., Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut 64 (2015), 673–683.
33. 33 Barres, R., Kirchner, H., Rasmussen, M., Yan, J., Kantor, F.R., Krook, A., Naslund, E., Zierath, J.R., Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep 3 (2013), 1020–1027.
34. 34 Grayson, B.E., Schneider, K.M., Woods, S.C., Seeley, R.J., Improved rodent maternal metabolism but reduced intrauterine growth after vertical sleeve gastrectomy. Sci Transl Med, 5, 2013, 199ra112.
35. 35 Salinari, S., le Roux, C.W., Bertuzzi, A., Rubino, F., Mingrone, G., Duodenal-jejunal bypass and jejuectomy improve insulin sensitivityin Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion. Diabetes 63 (2014), 1069–1078.
36. 36 Rasmussen, B.A., Breen, D.M., Duca, F.A., Cote, C.D., Zadeh-Tahmasebi, M., Filippi, B.M., Lam, T.K., Jejunal leptin-PI3K signaling lowers glucose production. Cell Metab 19 (2014), 155–161.
37. 37 Hotamisligil, G.S., Inflammation and metabolic disorders. Nature 444 (2006), 860–867.
38. 38 Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., Flier, J.S., TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116 (2006), 3015–3025.
39. 39 Vasconcelos, A.R., Yshii, L.M., Viel, T.A., Buck, H.S., Mattson, M.P., Scavone, C., Kawamoto, E.M., Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment. J Neuroinflammation, 11, 2014, 85.
40. 40 Lara-Padilla, E., Godinez-Victoria, M., Drago-Serrano, M.E., Reyna-Garfias, H., Arciniega-Martinez, I.M., Abarca-Rojano, E., Cruz-Hernandez, T.R., Campos-Rodriguez, R., Intermittent fasting modulates IgA levels in the small intestine under intense stress: a mouse model. J Neuroimmunol 285 (2015), 22–30.
41. 41 Carvalho, F.A., Koren, O., Goodrich, J.K., Johansson, M.E., Nalbantoglu, I., Aitken, J.D., Su, Y., Chassaing, B., Walters, W.A., Gonzalez, A., Clemente, J.C., Cullender, T.C., Barnich, N., Darfeuille-Michaud, A., Vijay-Kumar, M., Knight, R., Ley, R.E., Gewirtz, A.T., Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 12 (2012), 139–152.
42. 42 Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K.D., Verdu, E.F., Collins, S.M., The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141 (2011), 599–609 609.e1-e3.
43. 43 Schele, E., Grahnemo, L., Anesten, F., Hallen, A., Backhed, F., Jansson, J.O., The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology 154 (2013), 3643–3651.